Epistaxis (Nosebleeds) Clinical Trials Epistaxis (Nosebleeds) RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Sirolimus for Nosebleeds in HHT
Conditions:   Hereditary Hemorrhagic Telangiectasia;   Nosebleeds;   Epistaxis Intervention:   Drug: Sirolimus Sponsors:   Unity Health Toronto;   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2022 Category: Research Source Type: clinical trials

Comparison of a tube core and Magill forceps for nasotracheal intubation: a randomised controlled trial
ConclusionsWe conclude that using a tube core, consisting of a disposable sterilised stylet, is a convenient choice for NTI.Trial registrationPatient enrolment was conducted after registration in the Chinese Clinical Trial Registry (www.Chictr.org.cn, ChiCTR190002 7387). This trial was prospectively registered on 11 November 2019. (Source: Trials)
Source: Trials - October 13, 2021 Category: Research Source Type: clinical trials

Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients
Condition:   Telangiectasia, Hereditary Hemorrhagic Interventions:   Drug: Nintedanib;   Drug: Placebo Sponsors:   Dr. Romain Lazor;   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2021 Category: Research Source Type: clinical trials